NO178624C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer

Info

Publication number
NO178624C
NO178624C NO911368A NO911368A NO178624C NO 178624 C NO178624 C NO 178624C NO 911368 A NO911368 A NO 911368A NO 911368 A NO911368 A NO 911368A NO 178624 C NO178624 C NO 178624C
Authority
NO
Norway
Prior art keywords
substituted alkyl
therapeutically active
analogous process
preparing therapeutically
carbapenems
Prior art date
Application number
NO911368A
Other languages
English (en)
Norwegian (no)
Other versions
NO178624B (no
NO911368L (no
NO911368D0 (no
Inventor
Jr Carl B Ziegler
William V Curran
Gregg Feigelson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO911368D0 publication Critical patent/NO911368D0/no
Publication of NO911368L publication Critical patent/NO911368L/no
Priority to NO950203A priority Critical patent/NO179446C/no
Publication of NO178624B publication Critical patent/NO178624B/no
Publication of NO178624C publication Critical patent/NO178624C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO911368A 1990-04-10 1991-04-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer NO178624C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO950203A NO179446C (no) 1990-04-10 1995-01-19 Fremgangsmåte for fremstilling av propargylazetidion-forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/507,271 US5068232A (en) 1990-04-10 1990-04-10 Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them

Publications (4)

Publication Number Publication Date
NO911368D0 NO911368D0 (no) 1991-04-09
NO911368L NO911368L (no) 1991-10-11
NO178624B NO178624B (no) 1996-01-22
NO178624C true NO178624C (no) 1996-05-02

Family

ID=24017956

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911368A NO178624C (no) 1990-04-10 1991-04-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer

Country Status (20)

Country Link
US (3) US5068232A (sk)
EP (1) EP0478874A3 (sk)
JP (1) JPH04234885A (sk)
KR (1) KR0183020B1 (sk)
CN (3) CN1034332C (sk)
AU (1) AU634876B2 (sk)
CA (1) CA2039968A1 (sk)
CZ (1) CZ280808B6 (sk)
FI (1) FI95256C (sk)
HU (1) HU215606B (sk)
IE (1) IE910676A1 (sk)
IL (1) IL97275A (sk)
NO (1) NO178624C (sk)
NZ (1) NZ237610A (sk)
PH (1) PH27462A (sk)
PL (3) PL165937B1 (sk)
PT (1) PT97301B (sk)
SK (1) SK278900B6 (sk)
TW (1) TW229209B (sk)
ZA (1) ZA912629B (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104838D0 (en) * 1991-03-07 1991-04-17 Glaxo Spa Heterocyclic compounds
US5189158A (en) * 1991-03-20 1993-02-23 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
JP4212112B2 (ja) 1996-02-23 2009-01-21 イーライ・リリー・アンド・カンパニー 非ペプチジルバソプレッシンＶ１ａアンタゴニスト
WO2002066984A2 (en) * 2001-02-16 2002-08-29 Pepscan Systems B.V. Arrays for determining binding of biomolecules
CA2569116A1 (en) * 2004-06-10 2005-12-29 Fob Synthesis, Inc. Gram-positive carbapenem antibacterials and processes for their preparation
JPWO2006040893A1 (ja) * 2004-10-08 2008-05-15 大日本住友製薬株式会社 新規な抗菌性医薬
CN105906537B (zh) * 2016-04-27 2017-12-15 湖南科技学院 （z）式磺酰基烯酸酯化合物的一锅合成方法
CN105884663B (zh) * 2016-04-27 2017-12-15 湖南科技学院 一种(z)‑磺酰基烯酸酯的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122379A (en) * 1980-03-03 1981-09-25 Sankyo Co Ltd 1-carba-2-penem-3-carboxylic acid derivative
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
JPS58103388A (ja) * 1981-12-11 1983-06-20 Sankyo Co Ltd カルバペネム誘導体
JPH0649710B2 (ja) * 1984-08-06 1994-06-29 藤沢薬品工業株式会社 アゼチジノン誘導体およびその製造法
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge
US4882429A (en) * 1986-03-03 1989-11-21 Schering Corporation Stereospecific preparation of (3S,4R,5R)-3-(1-hydroxyethyl)-4-benzoyloxy-azeridinones from L-(-)-theonine
IT1197873B (it) * 1986-10-15 1988-12-21 Erba Farmitalia Procedimento per la preparazione di azetidinoni
DE3779856T2 (de) * 1986-10-16 1993-03-25 Merck & Co Inc Antibakterielle, 2-substituierte alkyl-carbapeneme.
US5021565A (en) * 1986-10-16 1991-06-04 Merck & Co., Inc. Novel 2-substituted alkyl carbapenem antibacterials
JPS63218659A (ja) * 1987-03-06 1988-09-12 Yasumitsu Tamura β−ラクタム化合物およびその製造法
JPH0193586A (ja) * 1987-10-05 1989-04-12 Yasumitsu Tamura カルバベネム化合物およびその製造法
US4960879A (en) * 1988-03-23 1990-10-02 Shionogi & Co., Ltd. Process for carbapenem intermediates
JPH0642853Y2 (ja) * 1988-10-28 1994-11-09 新王子製紙株式会社 プリンター
JPH03120280A (ja) * 1989-10-03 1991-05-22 Shionogi & Co Ltd ハロメチルカルバペネム化合物の製法

Also Published As

Publication number Publication date
KR910018384A (ko) 1991-11-30
AU7424891A (en) 1991-10-17
IE910676A1 (en) 1991-10-23
NZ237610A (en) 1995-02-24
FI95256B (fi) 1995-09-29
EP0478874A2 (en) 1992-04-08
NO178624B (no) 1996-01-22
IL97275A (en) 1996-01-31
US5480987A (en) 1996-01-02
CN1037177C (zh) 1998-01-28
ZA912629B (en) 1992-01-29
PT97301A (pt) 1992-01-31
CN1108649A (zh) 1995-09-20
US5369102A (en) 1994-11-29
FI911701A0 (fi) 1991-04-09
HUT57770A (en) 1991-12-30
IL97275A0 (en) 1992-05-25
SK278900B6 (sk) 1998-04-08
PL165952B1 (pl) 1995-03-31
TW229209B (sk) 1994-09-01
US5068232A (en) 1991-11-26
CS92991A3 (en) 1992-04-15
CN1034329C (zh) 1997-03-26
HU215606B (hu) 1999-01-28
PT97301B (pt) 1998-08-31
PL166336B1 (pl) 1995-05-31
CN1108648A (zh) 1995-09-20
HU911141D0 (en) 1991-10-28
EP0478874A3 (en) 1993-03-24
PL289814A1 (en) 1992-08-10
CN1034332C (zh) 1997-03-26
CZ280808B6 (cs) 1996-04-17
PH27462A (en) 1993-07-09
FI911701A (fi) 1991-10-11
PL294071A1 (sk) 1993-02-08
KR0183020B1 (ko) 1999-05-01
CA2039968A1 (en) 1991-10-11
PL165937B1 (pl) 1995-03-31
JPH04234885A (ja) 1992-08-24
CN1056878A (zh) 1991-12-11
FI95256C (fi) 1996-01-10
NO911368L (no) 1991-10-11
AU634876B2 (en) 1993-03-04
NO911368D0 (no) 1991-04-09

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO178498C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater
FI930723A (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
NO175714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO176142C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO178624C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer
NO175781C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI901883A0 (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
FI880190A (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater